D. Ford

Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a tissue‐nonspecific alkaline phosphatase inhibitor

J. Stark, H. Zahir, Sonomi Maruyama, 2022, Clinical and translational science.

Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients

T. Vollmer, J. Moberly, H. Zahir, 2012, Journal of Neuroimmunology.

Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes

A. Goldfine, V. Fonseca, K. Truitt, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.

J. Rosenstock, H. Chou, B. Tao, 2013, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly Patients

J. Gavin, K. Truitt, Michael R. Jones, 2014, Drugs & Aging.

Efficacy and Safety of Colesevelam in Combination with Pioglitazone in Patients with Type 2 Diabetes Mellitus

J. Rosenstock, K. Truitt, H. Chou, 2014, Hormone and Metabolic Research.